Twin Tree Management, LP Biogen Inc. Transaction History

Twin Tree Management, LP

$43.8 Billion
Q2 2024

A detailed history of Twin Tree Management, LP transactions in Biogen Inc. stock. As of the latest transaction made, Twin Tree Management, LP holds 1,737 shares of BIIB stock, worth $322,526. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,737

Previous 7,000 75.19%

Holding current value

$322,526

Previous $1.51 Million 73.36%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$190.52 - $236.72 $330,933 - $411,182	1,737 New	1,737 $402,000
Q2 2023 Aug 11, 2023	BUY	$275.25 - $318.06 $2.73 Million - $3.15 Million	9,913 Added 50.48%	29,552 $8.42 Million
Q1 2023 May 10, 2023	SELL	$256.56 - $292.34 $7.33 Million - $8.35 Million	-28,557 Reduced 59.25%	19,639 $5.46 Million
Q4 2022 Feb 13, 2023	SELL	$252.44 - $306.72 $16.6 Million - $20.1 Million	-65,616 Reduced 57.65%	48,196 $13.3 Million
Q3 2022 Nov 10, 2022	BUY	$194.69 - $268.46 $3.35 Million - $4.62 Million	17,208 Added 17.81%	113,812 $30.4 Million
Q2 2022 Aug 11, 2022	BUY	$187.54 - $223.02 $7.05 Million - $8.39 Million	37,607 Added 63.74%	96,604 $19.7 Million
Q1 2022 May 11, 2022	BUY	$193.77 - $244.14 $8.96 Million - $11.3 Million	46,220 Added 361.74%	58,997 $12.4 Million
Q2 2021 Aug 12, 2021	SELL	$259.0 - $414.71 $22.4 Million - $35.9 Million	-86,648 Reduced 87.15%	12,777 $4.42 Million
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $11.5 Million - $13.5 Million	47,309 Added 90.78%	99,425 $27.8 Million
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $4.29 Million - $6.46 Million	-18,162 Reduced 25.84%	52,116 $12.8 Million
Q3 2020 Nov 13, 2020	BUY	$264.77 - $305.71 $5.1 Million - $5.89 Million	19,261 Added 37.75%	70,278 $19.9 Million
Q2 2020 Aug 12, 2020	BUY	$258.66 - $342.55 $7.2 Million - $9.53 Million	27,831 Added 120.03%	51,017 $13.7 Million
Q1 2020 May 13, 2020	SELL	$268.85 - $341.04 $7.83 Million - $9.94 Million	-29,137 Reduced 55.69%	23,186 $7.34 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $6.47 Million - $8.94 Million	29,416 Added 128.41%	52,323 $15.5 Million
Q3 2019 Nov 12, 2019	SELL	$217.44 - $243.88 $517,724 - $580,678	-2,381 Reduced 9.42%	22,907 $5.33 Million
Q2 2019 Aug 12, 2019	SELL	$219.29 - $241.72 $1.8 Million - $1.99 Million	-8,214 Reduced 24.52%	25,288 $5.91 Million
Q1 2019 May 10, 2019	SELL	$216.71 - $338.96 $143,895 - $225,069	-664 Reduced 1.94%	33,502 $7.92 Million
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $9.32 Million - $11.8 Million	33,464 Added 4766.95%	34,166 $10.3 Million
Q3 2018 Nov 09, 2018	SELL	$293.51 - $383.83 $7.32 Million - $9.57 Million	-24,944 Reduced 97.26%	702 $248,000
Q2 2018 Aug 08, 2018	SELL	$257.52 - $306.91 $4.27 Million - $5.08 Million	-16,563 Reduced 39.24%	25,646 $7.44 Million
Q1 2018 May 09, 2018	BUY	$260.13 - $367.91 $9.12 Million - $12.9 Million	35,057 Added 490.17%	42,209 $11.6 Million
Q4 2017 Feb 09, 2018	BUY	$307.64 - $344.58 $2.2 Million - $2.46 Million	7,152	7,152 $2.28 Million

Others Institutions Holding BIIB

# of Institutions

1,049

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $26.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.

Account

Twin Tree Management, LP Biogen Inc. Transaction History